Quetiapine, an Atypical Antipsychotic, Is Protective against Autoimmune-Mediated Demyelination by Inhibiting Effector T Cell Proliferation
Open Access
- 13 August 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (8) , e42746
Abstract
Quetiapine (Que), a commonly used atypical antipsychotic drug (APD), can prevent myelin from breakdown without immune attack. Multiple sclerosisis (MS), an autoimmune reactive inflammation demyelinating disease, is triggered by activated myelin-specific T lymphocytes (T cells). In this study, we investigated the potential efficacy of Que as an immune-modulating therapeutic agent for experimental autoimmune encephalomyelitis (EAE), a mouse model for MS. Que treatment was initiated on the onset of MOG35–55 peptide induced EAE mice and the efficacy of Que on modulating the immune response was determined by Flow Cytometry through analyzing CD4+/CD8+ populations and the proliferation of effector T cells (CD4+CD25−) in peripheral immune organs. Our results show that Que dramatically attenuates the severity of EAE symptoms. Que treatment decreases the extent of CD4+/CD8+ T cell infiltration into the spinal cord and suppresses local glial activation, thereby diminishing the loss of mature oligodendrocytes and myelin breakdown in the spinal cord of EAE mice. Our results further demonstrate that Que treatment decreases the CD4+/CD8+ T cell populations in lymph nodes and spleens of EAE mice and inhibits either MOG35–55 or anti-CD3 induced proliferation as well as IL-2 production of effector T cells (CD4+CD25−) isolated from EAE mice spleen. Together, these findings suggest that Que displays an immune-modulating role during the course of EAE, and thus may be a promising candidate for treatment of MS.Keywords
This publication has 35 references indexed in Scilit:
- Mitochondria, oligodendrocytes and inflammation in bipolar disorder: Evidence from transcriptome studies points to intriguing parallels with multiple sclerosisNeurobiology of Disease, 2012
- Regulation of antigen-specific CTL and Th1 cell activation through 5-Hydroxytryptamine 2A receptorInternational Immunopharmacology, 2011
- Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patientsAnnals of Neurology, 2010
- Human Mesenchymal Stem Cells Infiltrate the Spinal Cord, Reduce Demyelination, and Localize to White Matter Lesions in Experimental Autoimmune EncephalomyelitisJournal of Neuropathology & Experimental Neurology, 2010
- Reversible neural stem cell niche dysfunction in a model of multiple sclerosisAnnals of Neurology, 2010
- Quetiapine for the treatment of alcoholism: Scientific rationale and review of the literatureDrug and Alcohol Review, 2010
- T cells in multiple sclerosis and experimental autoimmune encephalomyelitisClinical and Experimental Immunology, 2010
- Gene expression abnormalities and oligodendrocyte deficits in the internal capsule in schizophreniaSchizophrenia Research, 2010
- Adipose-Derived Mesenchymal Stem Cells Ameliorate Chronic Experimental Autoimmune EncephalomyelitisStem Cells, 2009
- Quetiapine alleviates the cuprizone-induced white matter pathology in the brain of C57BL/6 mouseSchizophrenia Research, 2008